These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 7527411

  • 21. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.
    Qin X, Byun D, Strong DD, Baylink DJ, Mohan S.
    J Bone Miner Res; 1999 Dec; 14(12):2079-88. PubMed ID: 10620067
    [Abstract] [Full Text] [Related]

  • 22. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
    Lalou C, Silve C, Rosato R, Segovia B, Binoux M.
    Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
    [Abstract] [Full Text] [Related]

  • 23. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S.
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [Abstract] [Full Text] [Related]

  • 24. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells.
    Cohick WS, Gockerman A, Clemmons DR.
    J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619
    [Abstract] [Full Text] [Related]

  • 25. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I.
    Bale LK, Conover CA.
    Endocrinology; 1992 Aug; 131(2):608-14. PubMed ID: 1379162
    [Abstract] [Full Text] [Related]

  • 26. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane.
    Sun IY, Overgaard MT, Oxvig C, Giudice LC.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5235-40. PubMed ID: 12414897
    [Abstract] [Full Text] [Related]

  • 27. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells.
    Knutsen R, Honda Y, Strong DD, Sampath TK, Baylink DJ, Mohan S.
    Endocrinology; 1995 Mar; 136(3):857-65. PubMed ID: 7532581
    [Abstract] [Full Text] [Related]

  • 28. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation.
    Giudice LC, Conover CA, Bale L, Faessen GH, Ilg K, Sun I, Imani B, Suen LF, Irwin JC, Christiansen M, Overgaard MT, Oxvig C.
    J Clin Endocrinol Metab; 2002 May; 87(5):2359-66. PubMed ID: 11994388
    [Abstract] [Full Text] [Related]

  • 29. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
    Park JH, McCusker RH, Vanderhoof JA, Mohammadpour H, Harty RF, MacDonald RG.
    Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
    [Abstract] [Full Text] [Related]

  • 30. Regulation of insulin-like growth factor-binding protein-4 protease activity by estrogen and parathyroid hormone in SaOS-2 cells: implications for the pathogenesis of postmenopausal osteoporosis.
    Kudo Y, Iwashita M, Itatsu S, Iguchi T, Takeda Y.
    J Endocrinol; 1996 Aug; 150(2):223-9. PubMed ID: 8869589
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS.
    J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).
    Angelloz-Nicoud P, Binoux M.
    Endocrinology; 1995 Dec; 136(12):5485-92. PubMed ID: 7588299
    [Abstract] [Full Text] [Related]

  • 35. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
    Imai Y, Busby WH, Smith CE, Clarke JB, Garmong AJ, Horwitz GD, Rees C, Clemmons DR.
    J Clin Invest; 1997 Nov 15; 100(10):2596-605. PubMed ID: 9366575
    [Abstract] [Full Text] [Related]

  • 36. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms.
    Martin JL, Ballesteros M, Baxter RC.
    Endocrinology; 1992 Oct 15; 131(4):1703-10. PubMed ID: 1382959
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
    Neely EK, Rosenfeld RG.
    Endocrinology; 1992 Feb 15; 130(2):985-93. PubMed ID: 1370799
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.